{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:19:53Z","timestamp":1787685593882,"version":"build-2784847793"},"reference-count":302,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for the Central Universities of Central South University","doi-asserted-by":"crossref","award":["2024ZZTS0148"],"award-info":[{"award-number":["2024ZZTS0148"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"crossref","award":["CX20240288"],"award-info":[{"award-number":["CX20240288"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82073097"],"award-info":[{"award-number":["82073097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hunan Provincial Key Area R&D Programs","award":["2021SK2013"],"award-info":[{"award-number":["2021SK2013"]}]},{"name":"the Science and Technology Innovation Program of Hunan Province","award":["2022RC3072"],"award-info":[{"award-number":["2022RC3072"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-026-00812-1","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:22:52Z","timestamp":1787638972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the role of glutamine metabolism in cancer: from cell death mechanisms to tumor microenvironment modulation"],"prefix":"10.1186","volume":"15","author":[{"given":"Xintong","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2354-5321","authenticated-orcid":false,"given":"Yongguang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"5","key":"812_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101077","volume":"6","author":"RA Ziki","year":"2024","unstructured":"Ziki RA, Colnot S. Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma. JHEP Rep. 2024;6(5):101077.","journal-title":"JHEP Rep"},{"issue":"6","key":"812_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1152\/jappl.1974.36.6.693","volume":"36","author":"J Bergstr\u00f6m","year":"1974","unstructured":"Bergstr\u00f6m J, F\u00fcrst P, Nor\u00e9e LO, Vinnars E. Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol. 1974;36(6):693\u20137.","journal-title":"J Appl Physiol"},{"issue":"3","key":"812_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21(3):162\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"812_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn UE, Peiris-Pag\u00e9s M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14(1):11\u201331.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"812_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer. 2016;16(10):619\u201334.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"812_CR6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin J, Byun JK, Choi YK, Park KG. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp Mol Med. 2023;55(4):706\u201315.","journal-title":"Exp Mol Med"},{"issue":"1","key":"812_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15(1):174.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"812_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-024-01977-1","volume":"23","author":"S Yang","year":"2024","unstructured":"Yang S, Hu C, Chen X, Tang Y, Li J, Yang H, et al. Crosstalk between metabolism and cell death in tumorigenesis. Mol Cancer. 2024;23(1):71.","journal-title":"Mol Cancer"},{"issue":"12","key":"812_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12(12):860\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"812_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","volume":"43","author":"P Kandasamy","year":"2018","unstructured":"Kandasamy P, Gyimesi G, Kanai Y, Hediger MA. Amino acid transporters revisited: new views in health and disease. Trends Biochem Sci. 2018;43(10):752\u201389.","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"812_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","volume":"31","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Park SJ, Nam M, Kang J, Kim K, Yeo JH, et al. A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells. Cell Metab. 2020;31(2):267-283.e212.","journal-title":"Cell Metab"},{"issue":"7721","key":"812_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0466-7","volume":"561","author":"G Eelen","year":"2018","unstructured":"Eelen G, Dubois C, Cantelmo AR, Goveia J, Br\u00fcning U, DeRan M, et al. Role of glutamine synthetase in angiogenesis beyond glutamine synthesis. Nature. 2018;561(7721):63\u20139.","journal-title":"Nature"},{"issue":"9","key":"812_CR13","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Yu YC, Sung Y, Han JM. Glutamine reliance in cell metabolism. Exp Mol Med. 2020;52(9):1496\u2013516.","journal-title":"Exp Mol Med"},{"issue":"3","key":"812_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","volume":"3","author":"AA Cluntun","year":"2017","unstructured":"Cluntun AA, Lukey MJ, Cerione RA, Locasale JW. Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer. 2017;3(3):169\u201380.","journal-title":"Trends Cancer"},{"issue":"5","key":"812_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cmet.2016.03.016","volume":"23","author":"JL Coloff","year":"2016","unstructured":"Coloff JL, Murphy JP, Braun CR, Harris IS, Shelton LM, Kami K, et al. Differential glutamate metabolism in proliferating and quiescent mammary epithelial cells. Cell Metab. 2016;23(5):867\u201380.","journal-title":"Cell Metab"},{"issue":"1","key":"812_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24859-2","volume":"12","author":"DM Kremer","year":"2021","unstructured":"Kremer DM, Nelson BS, Lin L, Yarosz EL, Halbrook CJ, Kerk SA, et al. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis. Nat Commun. 2021;12(1):4860.","journal-title":"Nat Commun"},{"issue":"1","key":"812_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cmet.2023.12.001","volume":"36","author":"MJ McBride","year":"2024","unstructured":"McBride MJ, Hunter CJ, Zhang Z, TeSlaa T, Xu X, Ducker GS, et al. Glycine homeostasis requires reverse SHMT flux. Cell Metab. 2024;36(1):103-115.e104.","journal-title":"Cell Metab"},{"issue":"5","key":"812_CR18","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2018.04.012","volume":"27","author":"M Luo","year":"2018","unstructured":"Luo M, Brooks M, Wicha MS. Asparagine and glutamine: co-conspirators fueling metastasis. Cell Metab. 2018;27(5):947\u20139.","journal-title":"Cell Metab"},{"issue":"10","key":"812_CR19","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang J, Pavlova NN, Thompson CB. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 2017;36(10):1302\u201315.","journal-title":"EMBO J"},{"issue":"5","key":"812_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"NJ Mullen","year":"2023","unstructured":"Mullen NJ, Singh PK. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat Rev Cancer. 2023;23(5):275\u201394.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"812_CR21","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.tcb.2023.03.003","volume":"33","author":"ES Ali","year":"2023","unstructured":"Ali ES, Ben-Sahra I. Regulation of nucleotide metabolism in cancers and immune disorders. Trends Cell Biol. 2023;33(11):950\u201366.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"812_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-022-01263-x","volume":"15","author":"HL Wu","year":"2022","unstructured":"Wu HL, Gong Y, Ji P, Xie YF, Jiang YZ, Liu GY. Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy. J Hematol Oncol. 2022;15(1):45.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"812_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2020.12.007","volume":"33","author":"YP Kang","year":"2021","unstructured":"Kang YP, Mockabee-Macias A, Jiang C, Falzone A, Prieto-Farigua N, Stone E, et al. Non-canonical glutamate-cysteine ligase activity protects against ferroptosis. Cell Metab. 2021;33(1):174-189.e177.","journal-title":"Cell Metab"},{"key":"812_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102066","volume":"92","author":"D Lapenna","year":"2023","unstructured":"Lapenna D. Glutathione and glutathione-dependent enzymes: from biochemistry to gerontology and successful aging. Ageing Res Rev. 2023;92:102066.","journal-title":"Ageing Res Rev"},{"issue":"8","key":"812_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620.","journal-title":"Protein Cell"},{"issue":"7443","key":"812_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013;496(7443):101\u20135.","journal-title":"Nature"},{"key":"812_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102065","volume":"46","author":"M Ying","year":"2021","unstructured":"Ying M, You D, Zhu X, Cai L, Zeng S, Hu X. Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions. Redox Biol. 2021;46:102065.","journal-title":"Redox Biol"},{"issue":"8","key":"812_CR28","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1164\/rccm.202203-0482OC","volume":"207","author":"EM Ryan","year":"2023","unstructured":"Ryan EM, Sadiku P, Coelho P, Watts ER, Zhang A, Howden AJM, et al. NRF2 activation reprograms defects in oxidative metabolism to restore macrophage function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2023;207(8):998\u20131011.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"812_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tcb.2025.07.005","volume":"26","author":"R Yang","year":"2025","unstructured":"Yang R, Guo Z, Li B. NADH reductive stress drives metabolic reprogramming. Trends Cell Biol. 2025;26(3):177\u201389.","journal-title":"Trends Cell Biol"},{"issue":"10","key":"812_CR30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1158\/1541-7786.MCR-23-0049","volume":"21","author":"H Jiang","year":"2023","unstructured":"Jiang H, He CJ, Li AM, He B, Li Y, Zhou MN, et al. Mitochondrial uncoupling inhibits reductive carboxylation in cancer cells. Mol Cancer Res. 2023;21(10):1010\u20136.","journal-title":"Mol Cancer Res"},{"issue":"36","key":"812_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2502483122","volume":"122","author":"H Jiang","year":"2025","unstructured":"Jiang H, Tiche SJ, He CJ, Liu J, Bian F, Jedoui M, et al. Restoring mitochondrial quantity and quality to reverse the Warburg effect and drive neuroblastoma differentiation. Proc Natl Acad Sci USA. 2025;122(36):e2502483122.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"812_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1083\/jcb.200703099","volume":"178","author":"M Yuneva","year":"2007","unstructured":"Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol. 2007;178(1):93\u2013105.","journal-title":"J Cell Biol"},{"issue":"11","key":"812_CR33","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/ncb3629","volume":"19","author":"MA Reid","year":"2017","unstructured":"Reid MA, Dai Z, Locasale JW. The impact of cellular metabolism on chromatin dynamics and epigenetics. Nat Cell Biol. 2017;19(11):1298\u2013306.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"812_CR34","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nrc.2016.82","volume":"16","author":"A Kinnaird","year":"2016","unstructured":"Kinnaird A, Zhao S, Wellen KE, Michelakis ED. Metabolic control of epigenetics in cancer. Nat Rev Cancer. 2016;16(11):694\u2013707.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"812_CR35","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1158\/2159-8290.CD-13-0092","volume":"3","author":"JK Killian","year":"2013","unstructured":"Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, et al. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov. 2013;3(6):648\u201357.","journal-title":"Cancer Discov"},{"issue":"3","key":"812_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13238-020-00796-6","volume":"12","author":"B Cong","year":"2021","unstructured":"Cong B, Zhang Q, Cao X. The function and regulation of TET2 in innate immunity and inflammation. Protein Cell. 2021;12(3):165\u201373.","journal-title":"Protein Cell"},{"issue":"2","key":"812_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.immuni.2025.01.007","volume":"58","author":"RM McManus","year":"2025","unstructured":"McManus RM, Komes MP, Griep A, Santarelli F, Schwartz S, Ram\u00f3n Perea J, et al. NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer\u2019s disease progression. Immunity. 2025;58(2):326-343.e311.","journal-title":"Immunity"},{"issue":"3","key":"812_CR38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41590-023-01430-3","volume":"24","author":"PS Liu","year":"2023","unstructured":"Liu PS, Chen YT, Li X, Hsueh PC, Tzeng SF, Chen H, et al. CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions. Nat Immunol. 2023;24(3):452\u201362.","journal-title":"Nat Immunol"},{"issue":"7","key":"812_CR39","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","volume":"175","author":"MO Johnson","year":"2018","unstructured":"Johnson MO, Wolf MM, Madden MZ, Andrejeva G, Sugiura A, Contreras DC, et al. Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism. Cell. 2018;175(7):1780-1795.e1719.","journal-title":"Cell"},{"issue":"6695","key":"812_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj4857","volume":"384","author":"J Ma","year":"2024","unstructured":"Ma J, Wu Y, Ma L, Yang X, Zhang T, Song G, et al. A blueprint for tumor-infiltrating B cells across human cancers. Science. 2024;384(6695):eadj4857.","journal-title":"Science"},{"issue":"9","key":"812_CR41","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"PS Liu","year":"2017","unstructured":"Liu PS, Wang H, Li X, Chao T, Teav T, Christen S, et al. \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol. 2017;18(9):985\u201394.","journal-title":"Nat Immunol"},{"key":"812_CR42","first-page":"88","volume":"5","author":"JL Garc\u00eda-Gim\u00e9nez","year":"2014","unstructured":"Garc\u00eda-Gim\u00e9nez JL, Pallard\u00f3 FV. Maintenance of glutathione levels and its importance in epigenetic regulation. Front Pharmacol. 2014;5:88.","journal-title":"Front Pharmacol"},{"issue":"16","key":"812_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/nu16162753","volume":"16","author":"L Federici","year":"2024","unstructured":"Federici L, Masulli M, De Laurenzi V, Allocati N. The role of S-glutathionylation in health and disease: a bird\u2019s eye view. Nutrients. 2024;16(16):2753.","journal-title":"Nutrients"},{"key":"812_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103116","volume":"71","author":"X Sun","year":"2024","unstructured":"Sun X, Guo C, Huang C, Lv N, Chen H, Huang H, et al. GSTP alleviates acute lung injury by S-glutathionylation of KEAP1 and subsequent activation of NRF2 pathway. Redox Biol. 2024;71:103116.","journal-title":"Redox Biol"},{"issue":"1","key":"812_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27428-9","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo Y, Liu Y, Zhao S, Xu W, Li Y, Zhao P, et al. Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages. Nat Commun. 2021;12(1):7094.","journal-title":"Nat Commun"},{"issue":"10","key":"812_CR46","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/ncb3410","volume":"18","author":"M Pan","year":"2016","unstructured":"Pan M, Reid MA, Lowman XH, Kulkarni RP, Tran TQ, Liu X, et al. Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation. Nat Cell Biol. 2016;18(10):1090\u2013101.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"812_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00482-x","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang J, Shay C, Saba NF, Teng Y. Cancer metabolism and carcinogenesis. Exp Hematol Oncol. 2024;13(1):10.","journal-title":"Exp Hematol Oncol"},{"issue":"6","key":"812_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tem.2019.03.003","volume":"30","author":"E Bernfeld","year":"2019","unstructured":"Bernfeld E, Foster DA. Glutamine as an essential amino acid for KRas-driven cancer cells. Trends Endocrinol Metab. 2019;30(6):357\u201368.","journal-title":"Trends Endocrinol Metab"},{"key":"812_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115464","volume":"210","author":"S Li","year":"2023","unstructured":"Li S, Zeng H, Fan J, Wang F, Xu C, Li Y, et al. Glutamine metabolism in breast cancer and possible therapeutic targets. Biochem Pharmacol. 2023;210:115464.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"812_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13045-022-01359-4","volume":"15","author":"T Liu","year":"2022","unstructured":"Liu T, Han C, Fang P, Ma Z, Wang X, Chen H, et al. Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma. J Hematol Oncol. 2022;15(1):141.","journal-title":"J Hematol Oncol"},{"issue":"16","key":"812_CR51","doi-asserted-by":"publisher","first-page":"7844","DOI":"10.7150\/thno.58655","volume":"11","author":"A Mukha","year":"2021","unstructured":"Mukha A, Kahya U, Linge A, Chen O, L\u00f6ck S, Lukiyanchuk V, et al. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy. Theranostics. 2021;11(16):7844\u201368.","journal-title":"Theranostics"},{"issue":"2","key":"812_CR52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/onc.2016.198","volume":"36","author":"BI Ratnikov","year":"2017","unstructured":"Ratnikov BI, Scott DA, Osterman AL, Smith JW, Ronai ZA. Metabolic rewiring in melanoma. Oncogene. 2017;36(2):147\u201357.","journal-title":"Oncogene"},{"issue":"Pt 3","key":"812_CR53","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.semcancer.2022.03.023","volume":"86","author":"C Zhang","year":"2022","unstructured":"Zhang C, Quinones A, Le A. Metabolic reservoir cycles in cancer. Semin Cancer Biol. 2022;86(Pt 3):180\u20138.","journal-title":"Semin Cancer Biol"},{"issue":"48","key":"812_CR54","doi-asserted-by":"publisher","first-page":"18782","DOI":"10.1073\/pnas.0810199105","volume":"105","author":"DR Wise","year":"2008","unstructured":"Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA. 2008;105(48):18782\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"812_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12964-023-01449-x","volume":"22","author":"X Li","year":"2024","unstructured":"Li X, Peng X, Li Y, Wei S, He G, Liu J, et al. Glutamine addiction in tumor cell: oncogene regulation and clinical treatment. Cell Commun Signal. 2024;22(1):12.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"812_CR56","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1182\/blood.2021013201","volume":"139","author":"ML Amaya","year":"2022","unstructured":"Amaya ML, Inguva A, Pei S, Jones C, Krug A, Ye H, et al. The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation. Blood. 2022;139(4):584\u201396.","journal-title":"Blood"},{"issue":"1","key":"812_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-019-1141-0","volume":"21","author":"MT Grinde","year":"2019","unstructured":"Grinde MT, Hilmarsdottir B, Tunset HM, Henriksen IM, Kim J, Haugen MH, et al. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer. Breast Cancer Res. 2019;21(1):61.","journal-title":"Breast Cancer Res"},{"key":"812_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115306","volume":"252","author":"Y Chen","year":"2023","unstructured":"Chen Y, Tan L, Gao J, Lin C, Wu F, Li Y, et al. Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics. Eur J Med Chem. 2023;252:115306.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"812_CR59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41419-018-1291-5","volume":"10","author":"L Xiang","year":"2019","unstructured":"Xiang L, Mou J, Shao B, Wei Y, Liang H, Takano N, et al. Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization. Cell Death Dis. 2019;10(2):40.","journal-title":"Cell Death Dis"},{"issue":"7239","key":"812_CR60","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458(7239):762\u20135.","journal-title":"Nature"},{"issue":"1","key":"812_CR61","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1152\/physrev.00045.2020","volume":"102","author":"E Crosas-Molist","year":"2022","unstructured":"Crosas-Molist E, Samain R, Kohlhammer L, Orgaz JL, George SL, Maiques O, et al. Rho GTPase signaling in cancer progression and dissemination. Physiol Rev. 2022;102(1):455\u2013510.","journal-title":"Physiol Rev"},{"issue":"5","key":"812_CR62","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/onc.2012.635","volume":"33","author":"MR Reynolds","year":"2014","unstructured":"Reynolds MR, Lane AN, Robertson B, Kemp S, Liu Y, Hill BG, et al. Control of glutamine metabolism by the tumor suppressor Rb. Oncogene. 2014;33(5):556\u201366.","journal-title":"Oncogene"},{"key":"812_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.108964","volume":"708","author":"HY Liu","year":"2021","unstructured":"Liu HY, Zhang HS, Liu MY, Li HM, Wang XY, Wang M. GLS1 depletion inhibited colorectal cancer proliferation and migration via redox\/Nrf2\/autophagy-dependent pathway. Arch Biochem Biophys. 2021;708:108964.","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"812_CR64","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.7150\/thno.80544","volume":"13","author":"N Li","year":"2023","unstructured":"Li N, Xu X, Liu D, Gao J, Gao Y, Wu X, et al. The delta subunit of the GABA(A) receptor is necessary for the GPT2-promoted breast cancer metastasis. Theranostics. 2023;13(4):1355\u201369.","journal-title":"Theranostics"},{"key":"812_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107415","volume":"165","author":"B Wang","year":"2023","unstructured":"Wang B, Pei J, Xu S, Liu J, Yu J. System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma. Comput Biol Med. 2023;165:107415.","journal-title":"Comput Biol Med"},{"issue":"18","key":"812_CR66","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-22-0042","volume":"82","author":"Y Li","year":"2022","unstructured":"Li Y, Li B, Xu Y, Qian L, Xu T, Meng G, et al. GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors. Cancer Res. 2022;82(18):3223\u201335.","journal-title":"Cancer Res"},{"issue":"1","key":"812_CR67","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1038\/s41467-018-07472-8","volume":"9","author":"N Santana-Codina","year":"2018","unstructured":"Santana-Codina N, Roeth AA, Zhang Y, Yang A, Mashadova O, Asara JM, et al. Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. Nat Commun. 2018;9(1):4945.","journal-title":"Nat Commun"},{"issue":"11","key":"812_CR68","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41419-022-05409-0","volume":"13","author":"X Yin","year":"2022","unstructured":"Yin X, Peng J, Gu L, Liu Y, Li X, Wu J, et al. Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis. Cell Death Dis. 2022;13(11):955.","journal-title":"Cell Death Dis"},{"issue":"8","key":"812_CR69","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.cell.2021.03.059","volume":"184","author":"A Csibi","year":"2021","unstructured":"Csibi A, Fendt SM, Li C, Poulogiannis G, Choo AY, Chapski DJ, et al. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell. 2021;184(8):2256.","journal-title":"Cell"},{"issue":"15","key":"812_CR70","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1038\/onc.2016.364","volume":"36","author":"A Cacace","year":"2017","unstructured":"Cacace A, Sboarina M, Vazeille T, Sonveaux P. Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism. Oncogene. 2017;36(15):2074\u201384.","journal-title":"Oncogene"},{"issue":"6218","key":"812_CR71","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.1259472","volume":"347","author":"JL Jewell","year":"2015","unstructured":"Jewell JL, Kim YC, Russell RC, Yu FX, Park HW, Plouffe SW, et al. Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science. 2015;347(6218):194\u20138.","journal-title":"Science"},{"issue":"10","key":"812_CR72","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/nm.3955","volume":"21","author":"D Herranz","year":"2015","unstructured":"Herranz D, Ambesi-Impiombato A, Sudderth J, S\u00e1nchez-Mart\u00edn M, Belver L, Tosello V, et al. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nat Med. 2015;21(10):1182\u20139.","journal-title":"Nat Med"},{"key":"812_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107292","volume":"206","author":"X Wang","year":"2024","unstructured":"Wang X, Gong W, Xiong X, Jia X, Xu J. Asparagine: a key metabolic junction in targeted tumor therapy. Pharmacol Res. 2024;206:107292.","journal-title":"Pharmacol Res"},{"issue":"2","key":"812_CR74","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00031.2024","volume":"105","author":"J Zheng","year":"2025","unstructured":"Zheng J, Conrad M. Ferroptosis: when metabolism meets cell death. Physiol Rev. 2025;105(2):651\u2013706.","journal-title":"Physiol Rev"},{"issue":"11","key":"812_CR75","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1158\/2159-8290.CD-13-0397","volume":"3","author":"AM Strohecker","year":"2013","unstructured":"Strohecker AM, Guo JY, Karsli-Uzunbas G, Price SM, Chen GJ, Mathew R, et al. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov. 2013;3(11):1272\u201385.","journal-title":"Cancer Discov"},{"key":"812_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174723","volume":"916","author":"HM Fares","year":"2022","unstructured":"Fares HM, Lyu X, Xu X, Dong R, Ding M, Mi S, et al. Autophagy in cancer: the cornerstone during glutamine deprivation. Eur J Pharmacol. 2022;916:174723.","journal-title":"Eur J Pharmacol"},{"key":"812_CR77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.semcancer.2020.03.010","volume":"66","author":"M Ishaq","year":"2020","unstructured":"Ishaq M, Ojha R, Sharma AP, Singh SK. Autophagy in cancer: recent advances and future directions. Semin Cancer Biol. 2020;66:171\u201381.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"812_CR78","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"812_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tips.2023.02.003","volume":"44","author":"V Jain","year":"2023","unstructured":"Jain V, Singh MP, Amaravadi RK. Recent advances in targeting autophagy in cancer. Trends Pharmacol Sci. 2023;44(5):290\u2013302.","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"812_CR80","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.4161\/auto.21228","volume":"8","author":"TC Lin","year":"2012","unstructured":"Lin TC, Chen YR, Kensicki E, Li AY, Kong M, Li Y, et al. Autophagy: resetting glutamine-dependent metabolism and oxygen consumption. Autophagy. 2012;8(10):1477\u201393.","journal-title":"Autophagy"},{"issue":"22","key":"812_CR81","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1101\/gad.269324.115","volume":"29","author":"J Ye","year":"2015","unstructured":"Ye J, Palm W, Peng M, King B, Lindsten T, Li MO, et al. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2. Genes Dev. 2015;29(22):2331\u20136.","journal-title":"Genes Dev"},{"issue":"1","key":"812_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.174","volume":"50","author":"BH Sohn","year":"2018","unstructured":"Sohn BH, Park IY, Shin JH, Yim SY, Lee JS. Glutamine synthetase mediates sorafenib sensitivity in \u03b2-catenin-active hepatocellular carcinoma cells. Exp Mol Med. 2018;50(1):e421.","journal-title":"Exp Mol Med"},{"issue":"12","key":"812_CR83","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.4161\/auto.22152","volume":"8","author":"KE van der Vos","year":"2012","unstructured":"van der Vos KE, Coffer PJ. Glutamine metabolism links growth factor signaling to the regulation of autophagy. Autophagy. 2012;8(12):1862\u20134.","journal-title":"Autophagy"},{"issue":"1","key":"812_CR84","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12964-019-0412-9","volume":"17","author":"WJ Zhou","year":"2019","unstructured":"Zhou WJ, Zhang J, Yang HL, Wu K, Xie F, Wu JN, et al. Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism. Cell Commun Signal. 2019;17(1):99.","journal-title":"Cell Commun Signal"},{"issue":"11","key":"812_CR85","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1080\/15548627.2022.2062875","volume":"18","author":"C Bodineau","year":"2022","unstructured":"Bodineau C, Tom\u00e9 M, Murdoch PDS, Dur\u00e1n RV. Glutamine, MTOR and autophagy: a multiconnection relationship. Autophagy. 2022;18(11):2749\u201350.","journal-title":"Autophagy"},{"issue":"17","key":"812_CR86","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.7150\/thno.60028","volume":"11","author":"S Han","year":"2021","unstructured":"Han S, Zhu L, Zhu Y, Meng Y, Li J, Song P, et al. Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition. Theranostics. 2021;11(17):8464\u201379.","journal-title":"Theranostics"},{"issue":"2","key":"812_CR87","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41418-022-01063-3","volume":"30","author":"J Li","year":"2023","unstructured":"Li J, Zhan H, Ren Y, Feng M, Wang Q, Jiao Q, et al. Sirtuin 4 activates autophagy and inhibits tumorigenesis by upregulating the p53 signaling pathway. Cell Death Differ. 2023;30(2):313\u201326.","journal-title":"Cell Death Differ"},{"issue":"6","key":"812_CR88","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/jimd.12061","volume":"42","author":"LR Soria","year":"2019","unstructured":"Soria LR, Brunetti-Pierri N. Ammonia and autophagy: an emerging relationship with implications for disorders with hyperammonemia. J Inherit Metab Dis. 2019;42(6):1097\u2013104.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"812_CR89","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/15548627.2015.1009778","volume":"11","author":"L Polletta","year":"2015","unstructured":"Polletta L, Vernucci E, Carnevale I, Arcangeli T, Rotili D, Palmerio S, et al. SIRT5 regulation of ammonia-induced autophagy and mitophagy. Autophagy. 2015;11(2):253\u201370.","journal-title":"Autophagy"},{"issue":"4","key":"812_CR90","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41419-019-1504-6","volume":"10","author":"S Zhao","year":"2019","unstructured":"Zhao S, Wang JM, Yan J, Zhang DL, Liu BQ, Jiang JY, et al. BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase. Cell Death Dis. 2019;10(4):284.","journal-title":"Cell Death Dis"},{"issue":"1","key":"812_CR91","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41419-020-2242-5","volume":"11","author":"DE Lee","year":"2020","unstructured":"Lee DE, Yoo JE, Kim J, Kim S, Kim S, Lee H, et al. NEDD4L downregulates autophagy and cell growth by modulating ULK1 and a glutamine transporter. Cell Death Dis. 2020;11(1):38.","journal-title":"Cell Death Dis"},{"key":"812_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101679","volume":"36","author":"W Ornatowski","year":"2020","unstructured":"Ornatowski W, Lu Q, Yegambaram M, Garcia AE, Zemskov EA, Maltepe E, et al. Complex interplay between autophagy and oxidative stress in the development of pulmonary disease. Redox Biol. 2020;36:101679.","journal-title":"Redox Biol"},{"key":"812_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.119449","volume":"307","author":"K Yin","year":"2022","unstructured":"Yin K, Wang D, Zhao H, Wang Y, Zhang Y, Liu Y, et al. Polystyrene microplastics up-regulates liver glutamine and glutamate synthesis and promotes autophagy-dependent ferroptosis and apoptosis in the cerebellum through the liver-brain axis. Environ Pollut. 2022;307:119449.","journal-title":"Environ Pollut"},{"issue":"Suppl (0)","key":"812_CR94","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","volume":"35","author":"RM Mohammad","year":"2015","unstructured":"Mohammad RM, Muqbil I, Lowe L, Yedjou C, Hsu HY, Lin LT, et al. Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol. 2015;35(Suppl (0)):S78-s103.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"812_CR95","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","volume":"20","author":"A Moyer","year":"2025","unstructured":"Moyer A, Tanaka K, Cheng EH. Apoptosis in cancer biology and therapy. Annu Rev Pathol. 2025;20(1):303\u201328.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"812_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01126-4","volume":"7","author":"E Ullrich","year":"2022","unstructured":"Ullrich E, Vogler M, von Metzler I. Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy. Signal Transduct Target Ther. 2022;7(1):291.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"812_CR97","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20(3):175\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"812_CR98","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1182\/blood-2018-02-791350","volume":"132","author":"R Valentin","year":"2018","unstructured":"Valentin R, Grabow S, Davids MS. The rise of apoptosis: targeting apoptosis in hematologic malignancies. Blood. 2018;132(12):1248\u201364.","journal-title":"Blood"},{"issue":"9","key":"812_CR99","doi-asserted-by":"publisher","first-page":"22830","DOI":"10.3390\/ijms160922830","volume":"16","author":"L Chen","year":"2015","unstructured":"Chen L, Cui H. Targeting glutamine induces apoptosis: a cancer therapy approach. Int J Mol Sci. 2015;16(9):22830\u201355.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"812_CR100","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.molcel.2022.03.016","volume":"82","author":"B Jiang","year":"2022","unstructured":"Jiang B, Zhang J, Zhao G, Liu M, Hu J, Lin F, et al. Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis. Mol Cell. 2022;82(10):1821-1835.e1826.","journal-title":"Mol Cell"},{"key":"812_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115101","volume":"202","author":"B Zhang","year":"2022","unstructured":"Zhang B, Fu R, Duan Z, Shen S, Zhu C, Fan D. Ginsenoside CK induces apoptosis in triple-negative breast cancer cells by targeting glutamine metabolism. Biochem Pharmacol. 2022;202:115101.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"812_CR102","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41419-022-04531-3","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Chen Y, Zhang M, Cheng H, Mai H, Yi M, et al. HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p\/USP6\/GLS1 axis. Cell Death Dis. 2022;13(1):92.","journal-title":"Cell Death Dis"},{"key":"812_CR103","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jare.2024.02.023","volume":"68","author":"J Li","year":"2025","unstructured":"Li J, Zhang D, Wang S, Yu P, Sun J, Zhang Y, et al. Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer. J Adv Res. 2025;68:341\u201357.","journal-title":"J Adv Res"},{"issue":"4","key":"812_CR104","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s12276-024-01231-0","volume":"56","author":"JH Kim","year":"2024","unstructured":"Kim JH, Lee J, Im SS, Kim B, Kim EY, Min HJ, et al. Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer. Exp Mol Med. 2024;56(4):1013\u201326.","journal-title":"Exp Mol Med"},{"issue":"10","key":"812_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05346-y","volume":"13","author":"R Yerbes","year":"2022","unstructured":"Yerbes R, Mora-Molina R, Fern\u00e1ndez-Farr\u00e1n FJ, Hiraldo L, L\u00f3pez-Rivas A, Palacios C. Limiting glutamine utilization activates a GCN2\/TRAIL-R2\/Caspase-8 apoptotic pathway in glutamine-addicted tumor cells. Cell Death Dis. 2022;13(10):906.","journal-title":"Cell Death Dis"},{"issue":"3","key":"812_CR106","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1158\/2643-3230.BCD-20-0168","volume":"2","author":"D Yan","year":"2021","unstructured":"Yan D, Franzini A, Pomicter AD, Halverson BJ, Antelope O, Mason CC, et al. SIRT5 is a druggable metabolic vulnerability in acute myeloid leukemia. Blood Cancer Discov. 2021;2(3):266\u201387.","journal-title":"Blood Cancer Discov"},{"issue":"6","key":"812_CR107","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1080\/15548627.2017.1299315","volume":"13","author":"VH Villar","year":"2017","unstructured":"Villar VH, Dur\u00e1n RV. Glutamoptosis: a new cell death mechanism inhibited by autophagy during nutritional imbalance. Autophagy. 2017;13(6):1078\u20139.","journal-title":"Autophagy"},{"key":"812_CR108","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.canlet.2018.01.061","volume":"420","author":"J Ye","year":"2018","unstructured":"Ye J, Zhang R, Wu F, Zhai L, Wang K, Xiao M, et al. Non-apoptotic cell death in malignant tumor cells and natural compounds. Cancer Lett. 2018;420:210\u201327.","journal-title":"Cancer Lett"},{"issue":"3","key":"812_CR109","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.bbamcr.2016.12.016","volume":"1864","author":"K Valter","year":"2017","unstructured":"Valter K, Chen L, Kruspig B, Maximchik P, Cui H, Zhivotovsky B, et al. Contrasting effects of glutamine deprivation on apoptosis induced by conventionally used anticancer drugs. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2017;1864(3):498\u2013506.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"issue":"2","key":"812_CR110","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/jm500695e","volume":"58","author":"MP Bourbeau","year":"2015","unstructured":"Bourbeau MP, Bartberger MD. Recent advances in the development of acetyl-CoA carboxylase (ACC) inhibitors for the treatment of metabolic disease. J Med Chem. 2015;58(2):525\u201336.","journal-title":"J Med Chem"},{"key":"812_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.03.002","author":"B Zhou","year":"2019","unstructured":"Zhou B, Liu J, Kang R, Klionsky DJ, Kroemer G, Tang D. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. 2019. https:\/\/doi.org\/10.1016\/j.semcancer.2019.03.002.","journal-title":"Semin Cancer Biol"},{"key":"812_CR112","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5080843","author":"LJ Su","year":"2019","unstructured":"Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/5080843.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"812_CR113","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280\u201396.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"812_CR114","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"3","key":"812_CR115","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017;482(3):419\u201325.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"812_CR116","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"issue":"7","key":"812_CR117","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"812_CR118","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","volume":"22","author":"X Liu","year":"2020","unstructured":"Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X, et al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol. 2020;22(4):476\u201386.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"812_CR119","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20(10):1181\u201392.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"812_CR120","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1111\/cas.14182","volume":"110","author":"S Okazaki","year":"2019","unstructured":"Okazaki S, Umene K, Yamasaki J, Suina K, Otsuki Y, Yoshikawa M, et al. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma. Cancer Sci. 2019;110(11):3453\u201363.","journal-title":"Cancer Sci"},{"issue":"6","key":"812_CR121","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41375-022-01573-6","volume":"36","author":"B Pardieu","year":"2022","unstructured":"Pardieu B, Pasanisi J, Ling F, Dal Bello R, Penneroux J, Su A, et al. Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia. Leukemia. 2022;36(6):1585\u201395.","journal-title":"Leukemia"},{"issue":"1","key":"812_CR122","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40164-024-00489-4","volume":"13","author":"S Feng","year":"2024","unstructured":"Feng S, Yuan Y, Lin Z, Li M, Ye D, Shi L, et al. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia. Exp Hematol Oncol. 2024;13(1):19.","journal-title":"Exp Hematol Oncol"},{"issue":"8","key":"812_CR123","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-017-0053-8","volume":"25","author":"M Luo","year":"2018","unstructured":"Luo M, Wu L, Zhang K, Wang H, Zhang T, Gutierrez L, et al. MiR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. Cell Death Differ. 2018;25(8):1457\u201372.","journal-title":"Cell Death Differ"},{"key":"812_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216727","volume":"588","author":"A Song","year":"2024","unstructured":"Song A, Wu L, Zhang BX, Yang QC, Liu YT, Li H, et al. Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma. Cancer Lett. 2024;588:216727.","journal-title":"Cancer Lett"},{"issue":"3","key":"812_CR125","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bjh.18884","volume":"202","author":"Z Ma","year":"2023","unstructured":"Ma Z, Ye W, Wang J, Huang X, Huang J, Li X, et al. Glutamate dehydrogenase 1: a novel metabolic target in inhibiting acute myeloid leukaemia progression. Br J Haematol. 2023;202(3):566\u201377.","journal-title":"Br J Haematol"},{"issue":"10","key":"812_CR126","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/1535-7163.MCT-23-0041","volume":"22","author":"G Venkateswaran","year":"2023","unstructured":"Venkateswaran G, McDonald PC, Chafe SC, Brown WS, Gerbec ZJ, Awrey SJ, et al. A Carbonic anhydrase IX\/SLC1A5 axis regulates glutamine metabolism dependent ferroptosis in hypoxic tumor cells. Mol Cancer Ther. 2023;22(10):1228\u201342.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"812_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05803-6","volume":"22","author":"X Huang","year":"2024","unstructured":"Huang X, Xia K, Wei Z, Liu W, Wei Z, Guo W. SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K\/AKT\/mTOR signaling in osteosarcoma. J Transl Med. 2024;22(1):1004.","journal-title":"J Transl Med"},{"issue":"1\u20133","key":"812_CR128","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/ars.2022.0203","volume":"39","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang Y, Lin Z, Kang R, Tang D, Liu J. SLC25A22 as a key mitochondrial transporter against ferroptosis by producing glutathione and monounsaturated fatty acids. Antioxid Redox Signal. 2023;39(1\u20133):166\u201385.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"812_CR129","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, et al. Role of mitochondria in ferroptosis. Mol Cell. 2019;73(2):354-363.e353.","journal-title":"Mol Cell"},{"issue":"18","key":"812_CR130","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/0008-5472.CAN-21-3914","volume":"82","author":"S Suzuki","year":"2022","unstructured":"Suzuki S, Venkatesh D, Kanda H, Nakayama A, Hosokawa H, Lee E, et al. GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma. Cancer Res. 2022;82(18):3209\u201322.","journal-title":"Cancer Res"},{"issue":"1","key":"812_CR131","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41420-023-01475-1","volume":"9","author":"Y Cai","year":"2023","unstructured":"Cai Y, Lv L, Lu T, Ding M, Yu Z, Chen X, et al. \u03b1-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis. Cell Death Discov. 2023;9(1):182.","journal-title":"Cell Death Discov"},{"issue":"2","key":"812_CR132","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59(2):298\u2013308.","journal-title":"Mol Cell"},{"issue":"4\u20136","key":"812_CR133","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1089\/ars.2023.0384","volume":"41","author":"J Wu","year":"2024","unstructured":"Wu J, Han W, Zhang Y, Li S, Qin T, Huang Z, et al. Glutamine mitigates oxidative stress-induced matrix degradation, ferroptosis, and pyroptosis in nucleus pulposus cells via deubiquitinating and stabilizing Nrf2. Antioxid Redox Signal. 2024;41(4\u20136):278\u201395.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"812_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101928","volume":"6","author":"X Shen","year":"2025","unstructured":"Shen X, Chen Y, Tang Y, Lu P, Liu M, Mao T, et al. Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis. Cell Rep Med. 2025;6(2):101928.","journal-title":"Cell Rep Med"},{"issue":"3","key":"812_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111498","volume":"41","author":"L Xie","year":"2022","unstructured":"Xie L, Yuan Y, Xu S, Lu S, Gu J, Wang Y, et al. Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex. Cell Rep. 2022;41(3):111498.","journal-title":"Cell Rep"},{"issue":"6586","key":"812_CR136","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361.","journal-title":"Science"},{"issue":"20","key":"812_CR137","doi-asserted-by":"publisher","first-page":"19581","DOI":"10.1021\/acsnano.3c07775","volume":"17","author":"W Wang","year":"2023","unstructured":"Wang W, Mo W, Hang Z, Huang Y, Yi H, Sun Z, et al. Cuproptosis: harnessing transition metal for cancer therapy. ACS Nano. 2023;17(20):19581\u201399.","journal-title":"ACS Nano"},{"issue":"2","key":"812_CR138","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41589-022-01159-4","volume":"19","author":"V Schulz","year":"2023","unstructured":"Schulz V, Basu S, Freibert SA, Webert H, Boss L, M\u00fchlenhoff U, et al. Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nat Chem Biol. 2023;19(2):206\u201317.","journal-title":"Nat Chem Biol"},{"issue":"35","key":"812_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202404971","volume":"36","author":"S Lu","year":"2024","unstructured":"Lu S, Li Y, Yu Y. Glutathione-scavenging celastrol-Cu nanoparticles induce self-amplified cuproptosis for augmented cancer immunotherapy. Adv Mater. 2024;36(35):e2404971.","journal-title":"Adv Mater"},{"issue":"Pt 2","key":"812_CR140","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.freeradbiomed.2022.11.023","volume":"193","author":"Y Yang","year":"2022","unstructured":"Yang Y, Liang S, Geng H, Xiong M, Li M, Su Q, et al. Proteomics revealed the crosstalk between copper stress and cuproptosis, and explored the feasibility of curcumin as anticancer copper ionophore. Free Radic Biol Med. 2022;193(Pt 2):638\u201347.","journal-title":"Free Radic Biol Med"},{"key":"812_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112912","volume":"140","author":"D Wang","year":"2024","unstructured":"Wang D, Deng X, Li S, Sana S. Impact of SARS-CoV-2 infection on immune cell cuproptosis in patients with lung adenocarcinoma via glutamine regulation. Int Immunopharmacol. 2024;140:112912.","journal-title":"Int Immunopharmacol"},{"key":"812_CR142","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jconrel.2024.05.045","volume":"371","author":"N Zhang","year":"2024","unstructured":"Zhang N, Ping W, Rao K, Zhang Z, Huang R, Zhu D, et al. Biomimetic copper-doped polypyrrole nanoparticles induce glutamine metabolism inhibition to enhance breast cancer cuproptosis and immunotherapy. J Control Release. 2024;371:204\u201315.","journal-title":"J Control Release"},{"issue":"1","key":"812_CR143","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","volume":"42","author":"P Zheng","year":"2023","unstructured":"Zheng P, Zhou C, Ding Y, Duan S. Disulfidptosis: a new target for metabolic cancer therapy. J Exp Clin Cancer Res. 2023;42(1):103.","journal-title":"J Exp Clin Cancer Res"},{"key":"812_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113739","volume":"383","author":"Y Li","year":"2025","unstructured":"Li Y, Lu Y, Lu W, Zhong N, Li N, Xu Z, et al. Transformable albumin-based nanocapsules selectively amplify tumor starvation and disulfidptosis through metabolic deception. J Control Release. 2025;383:113739.","journal-title":"J Control Release"},{"issue":"1","key":"812_CR145","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trecan.2021.09.003","volume":"8","author":"J Yan","year":"2022","unstructured":"Yan J, Wan P, Choksi S, Liu ZG. Necroptosis and tumor progression. Trends Cancer. 2022;8(1):21\u20137.","journal-title":"Trends Cancer"},{"issue":"4","key":"812_CR146","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mco2.108","volume":"2","author":"X Liu","year":"2020","unstructured":"Liu X, Xie X, Ren Y, Shao Z, Zhang N, Li L, et al. The role of necroptosis in disease and treatment. MedComm. 2020;2(4):730\u201355.","journal-title":"MedComm"},{"issue":"Pt 3","key":"812_CR147","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2022.07.007","volume":"86","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang Y, Inuzuka H, Wei W. Necroptosis pathways in tumorigenesis. Semin Cancer Biol. 2022;86(Pt 3):32\u201340.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"812_CR148","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"R Tang","year":"2020","unstructured":"Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13(1):110.","journal-title":"J Hematol Oncol"},{"issue":"29","key":"812_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309203","volume":"11","author":"Q Zheng","year":"2024","unstructured":"Zheng Q, Zou T, Wang W, Zhang C, Hu S, Cheng X, et al. Necroptosis-mediated synergistic photodynamic and glutamine-metabolic therapy enabled by a biomimetic targeting nanosystem for cholangiocarcinoma. Adv Sci (Weinh). 2024;11(29):e2309203.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"812_CR150","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41556-017-0022-y","volume":"20","author":"Z Yang","year":"2018","unstructured":"Yang Z, Wang Y, Zhang Y, He X, Zhong CQ, Ni H, et al. RIP3 targets pyruvate dehydrogenase complex to increase aerobic respiration in TNF-induced necroptosis. Nat Cell Biol. 2018;20(2):186\u201397.","journal-title":"Nat Cell Biol"},{"key":"812_CR151","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molimm.2022.04.009","volume":"147","author":"L Pan","year":"2022","unstructured":"Pan L, Yang L, Yi Z, Zhang W, Gong J. TBK1 participates in glutaminolysis by mediating the phosphorylation of RIPK3 to promote endotoxin tolerance. Mol Immunol. 2022;147:101\u201314.","journal-title":"Mol Immunol"},{"issue":"1","key":"812_CR152","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12974-022-02626-4","volume":"19","author":"M Liu","year":"2022","unstructured":"Liu M, Li H, Yang R, Ji D, Xia X. GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1\/RIP3\/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma. J Neuroinflammation. 2022;19(1):262.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"812_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02158-1","volume":"10","author":"YC Liu","year":"2024","unstructured":"Liu YC, Liu SY, Lin YC, Liu CJ, Chang KW, Lin SC. The disruption of NEAT1-miR-125b-5p-SLC1A5 cascade defines the oncogenicity and differential immune profile in head and neck squamous cell carcinoma. Cell Death Discov. 2024;10(1):392.","journal-title":"Cell Death Discov"},{"key":"812_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101170","volume":"78","author":"X Niu","year":"2025","unstructured":"Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, et al. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resist Updat. 2025;78:101170.","journal-title":"Drug Resist Updat"},{"issue":"8","key":"812_CR155","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ 3rd, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12(8):1425\u20138.","journal-title":"Autophagy"},{"key":"812_CR156","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cytogfr.2023.06.002","volume":"71\u201372","author":"Y Xie","year":"2023","unstructured":"Xie Y, Lei X, Zhao G, Guo R, Cui N. mTOR in programmed cell death and its therapeutic implications. Cytokine Growth Factor Rev. 2023;71\u201372:66\u201381.","journal-title":"Cytokine Growth Factor Rev"},{"key":"812_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216662","volume":"585","author":"U Biswas","year":"2024","unstructured":"Biswas U, Roy R, Ghosh S, Chakrabarti G. The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics. Cancer Lett. 2024;585:216662.","journal-title":"Cancer Lett"},{"key":"812_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154943","volume":"118","author":"X Liu","year":"2023","unstructured":"Liu X, Liu L, Wang X, Jin Y, Wang S, Xie Q, et al. Necroptosis inhibits autophagy by regulating the formation of RIP3\/p62\/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer. Phytomedicine. 2023;118:154943.","journal-title":"Phytomedicine"},{"issue":"1","key":"812_CR159","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40164-025-00689-6","volume":"14","author":"R Wang","year":"2025","unstructured":"Wang R, Zhuang J, Zhang Q, Wu W, Yu X, Zhang H, et al. Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies. Exp Hematol Oncol. 2025;14(1):99.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"812_CR160","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13046-024-02994-0","volume":"43","author":"B Wang","year":"2024","unstructured":"Wang B, Pei J, Xu S, Liu J, Yu J. A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle. J Exp Clin Cancer Res. 2024;43(1):74.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7972","key":"812_CR161","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","volume":"620","author":"C Guo","year":"2023","unstructured":"Guo C, You Z, Shi H, Sun Y, Du X, Palacios G, et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature. 2023;620(7972):200\u20138.","journal-title":"Nature"},{"key":"812_CR162","doi-asserted-by":"publisher","DOI":"10.3390\/nu10111564","author":"V Cruzat","year":"2018","unstructured":"Cruzat V, Macedo Rogero M, Noel Keane K, Curi R, Newsholme P. Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10111564.","journal-title":"Nutrients"},{"issue":"1","key":"812_CR163","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Ther. 2023;8(1):235.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"812_CR164","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ni.2556","volume":"14","author":"LV Sinclair","year":"2013","unstructured":"Sinclair LV, Rolf J, Emslie E, Shi YB, Taylor PM, Cantrell DA. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol. 2013;14(5):500\u20138.","journal-title":"Nat Immunol"},{"issue":"6","key":"812_CR165","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cmet.2018.08.009","volume":"28","author":"S Ricciardi","year":"2018","unstructured":"Ricciardi S, Manfrini N, Alfieri R, Calamita P, Crosti MC, Gallo S, et al. The translational machinery of human CD4(+) T cells is poised for activation and controls the switch from quiescence to metabolic remodeling. Cell Metab. 2018;28(6):895-906.e895.","journal-title":"Cell Metab"},{"issue":"12","key":"812_CR166","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.160345","volume":"8","author":"K Lee","year":"2023","unstructured":"Lee K, Thompson EA, Gharaie S, Patel CH, Kurzhagen JT, Pierorazio PM, et al. T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade. JCI Insight. 2023;8(12):e160345.","journal-title":"JCI Insight"},{"issue":"4","key":"812_CR167","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140100","volume":"131","author":"DN Edwards","year":"2021","unstructured":"Edwards DN, Ngwa VM, Raybuck AL, Wang S, Hwang Y, Kim LC, et al. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. J Clin Invest. 2021;131(4):e140100.","journal-title":"J Clin Invest"},{"issue":"14","key":"812_CR168","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1073\/pnas.1504279112","volume":"112","author":"T Willinger","year":"2015","unstructured":"Willinger T, Staron M, Ferguson SM, De Camilli P, Flavell RA. Dynamin 2-dependent endocytosis sustains T-cell receptor signaling and drives metabolic reprogramming in T lymphocytes. Proc Natl Acad Sci USA. 2015;112(14):4423\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"812_CR169","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.immuni.2019.10.001","volume":"51","author":"H Shi","year":"2019","unstructured":"Shi H, Chapman NM, Wen J, Guy C, Long L, Dhungana Y, et al. Amino acids license kinase mTORC1 activity and Treg cell function via small G proteins Rag and Rheb. Immunity. 2019;51(6):1012-1027.e1017.","journal-title":"Immunity"},{"issue":"1","key":"812_CR170","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00575-7","volume":"13","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Zheng J, Lu Y, Mai Z, Lin Y, Lin P, et al. Optimizing CD8(+) T cell-based immunotherapy via metabolic interventions: a comprehensive review of intrinsic and extrinsic modulators. Exp Hematol Oncol. 2024;13(1):103.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"812_CR171","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.apsb.2019.12.006","volume":"10","author":"W Song","year":"2020","unstructured":"Song W, Li D, Tao L, Luo Q, Chen L. Solute carrier transporters: the metabolic gatekeepers of immune cells. Acta Pharm Sin B. 2020;10(1):61\u201378.","journal-title":"Acta Pharm Sin B"},{"issue":"43","key":"812_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403629","volume":"11","author":"X Zhou","year":"2024","unstructured":"Zhou X, Chen Z, Yu Y, Li M, Cao Y, Prochownik EV, et al. Increases in 4-acetaminobutyric acid generated by phosphomevalonate kinase suppress CD8(+) T cell activation and allow tumor immune escape. Adv Sci (Weinh). 2024;11(43):e2403629.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"812_CR173","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","volume":"13","author":"Y Yin","year":"2024","unstructured":"Yin Y, Feng W, Chen J, Chen X, Wang G, Wang S, et al. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside. Exp Hematol Oncol. 2024;13(1):72.","journal-title":"Exp Hematol Oncol"},{"key":"812_CR174","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202502225","author":"T Ren","year":"2025","unstructured":"Ren T, Qiu J, Chen F, Jiang Q, Liu Q, Wu T, et al. Targeting glutamine metabolism transporter SLC25A22 enhances CD8+ T-cell function and anti-PD-1 therapy efficacy in cervical squamous cell carcinoma: integrated metabolomics, transcriptomics and T-cell-incorporated tumor organoid studies. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202502225.","journal-title":"Adv Sci"},{"issue":"24","key":"812_CR175","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1182\/blood.2024027496","volume":"146","author":"F Navarro","year":"2025","unstructured":"Navarro F, Lozano T, Fuentes-Garc\u00eda A, S\u00e1nchez-Moreno I, Larrayoz M, Justicia P, et al. Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma. Blood. 2025;146(24):2931\u201344.","journal-title":"Blood"},{"issue":"1","key":"812_CR176","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00535-1","volume":"13","author":"A Van der Vreken","year":"2024","unstructured":"Van der Vreken A, Vanderkerken K, De Bruyne E, De Veirman K, Breckpot K, Menu E. Fueling CARs: metabolic strategies to enhance CAR T-cell therapy. Exp Hematol Oncol. 2024;13(1):66.","journal-title":"Exp Hematol Oncol"},{"issue":"10","key":"812_CR177","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41590-024-01923-9","volume":"25","author":"C Scirgolea","year":"2024","unstructured":"Scirgolea C, Sottile R, De Luca M, Susana A, Carnevale S, Puccio S, et al. NaCl enhances CD8(+) T cell effector functions in cancer immunotherapy. Nat Immunol. 2024;25(10):1845\u201357.","journal-title":"Nat Immunol"},{"issue":"10","key":"812_CR178","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1172\/JCI129269","volume":"130","author":"X Xia","year":"2020","unstructured":"Xia X, Cao G, Sun G, Zhu L, Tian Y, Song Y, et al. GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis. J Clin Invest. 2020;130(10):5180\u201396.","journal-title":"J Clin Invest"},{"issue":"9","key":"812_CR179","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.7150\/thno.54803","volume":"11","author":"Y Miao","year":"2021","unstructured":"Miao Y, Zheng Y, Geng Y, Yang L, Cao N, Dai Y, et al. The role of GLS1-mediated glutaminolysis\/2-HG\/H3K4me3 and GSH\/ROS signals in Th17 responses counteracted by PPAR\u03b3 agonists. Theranostics. 2021;11(9):4531\u201348.","journal-title":"Theranostics"},{"issue":"1","key":"812_CR180","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57603-1","volume":"16","author":"Z Wen","year":"2025","unstructured":"Wen Z, Liu T, Xu X, Acharya N, Shen Z, Lu Y, et al. Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice. Nat Commun. 2025;16(1):2362.","journal-title":"Nat Commun"},{"issue":"1","key":"812_CR181","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12951-022-01424-7","volume":"20","author":"Y Tang","year":"2022","unstructured":"Tang Y, Wang S, Li Y, Yuan C, Zhang J, Xu Z, et al. Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer. J Nanobiotechnol. 2022;20(1):216.","journal-title":"J Nanobiotechnol"},{"issue":"26","key":"812_CR182","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105885","volume":"9","author":"M Huang","year":"2022","unstructured":"Huang M, Xiong D, Pan J, Zhang Q, Sei S, Shoemaker RH, et al. Targeting glutamine metabolism to enhance immunoprevention of EGFR-driven lung cancer. Adv Sci (Weinh). 2022;9(26):e2105885.","journal-title":"Adv Sci (Weinh)"},{"key":"812_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215710","volume":"538","author":"L Shen","year":"2022","unstructured":"Shen L, Xiao Y, Zhang C, Li S, Teng X, Cui L, et al. Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity. Cancer Lett. 2022;538:215710.","journal-title":"Cancer Lett"},{"key":"812_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1251643","volume":"14","author":"R Huang","year":"2023","unstructured":"Huang R, Wang H, Hong J, Wu J, Huang O, He J, et al. Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer. Front Immunol. 2023;14:1251643.","journal-title":"Front Immunol"},{"issue":"2","key":"812_CR185","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2017.12.007","volume":"27","author":"S Jiang","year":"2018","unstructured":"Jiang S, Yan W, Wang SE, Baltimore D. Let-7 suppresses B cell activation through restricting the availability of necessary nutrients. Cell Metab. 2018;27(2):393-403.e394.","journal-title":"Cell Metab"},{"issue":"3","key":"812_CR186","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41590-025-02102-0","volume":"26","author":"E Martinis","year":"2025","unstructured":"Martinis E, Tonon S, Colamatteo A, La Cava A, Matarese G, Pucillo CEM. B cell immunometabolism in health and disease. Nat Immunol. 2025;26(3):366\u201377.","journal-title":"Nat Immunol"},{"key":"812_CR187","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.isci.2018.07.005","volume":"5","author":"LR Waters","year":"2018","unstructured":"Waters LR, Ahsan FM, Wolf DM, Shirihai O, Teitell MA. Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling. iScience. 2018;5:99\u2013109.","journal-title":"iScience"},{"issue":"1","key":"812_CR188","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","volume":"15","author":"A Le","year":"2012","unstructured":"Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012;15(1):110\u201321.","journal-title":"Cell Metab"},{"issue":"2","key":"812_CR189","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41385-021-00481-9","volume":"15","author":"JQ Liu","year":"2022","unstructured":"Liu JQ, Geng XR, Hu TY, Mo LH, Luo XQ, Qiu SY, et al. Glutaminolysis is required in maintaining immune regulatory functions in B cells. Mucosal Immunol. 2022;15(2):268\u201378.","journal-title":"Mucosal Immunol"},{"key":"812_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109133","volume":"112","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang G, Bi Y, Jiang Z, Wang X. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR\/P70S6K\/4EBP1 and NLRP3\/caspase-1\/IL-1\u03b2 pathways in MRL\/lpr mice. Int Immunopharmacol. 2022;112:109133.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"812_CR191","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40164-024-00561-z","volume":"13","author":"Y Shi","year":"2024","unstructured":"Shi Y, Hao D, Qian H, Tao Z. Natural killer cell-based cancer immunotherapy: from basics to clinical trials. Exp Hematol Oncol. 2024;13(1):101.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"812_CR192","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40164-024-00511-9","volume":"13","author":"J Hou","year":"2024","unstructured":"Hou J, Xie S, Gao J, Jiang T, Zhu E, Yang X, et al. NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice. Exp Hematol Oncol. 2024;13(1):48.","journal-title":"Exp Hematol Oncol"},{"issue":"6","key":"812_CR193","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.4049\/jimmunol.1700497","volume":"199","author":"H Jensen","year":"2017","unstructured":"Jensen H, Potempa M, Gotthardt D, Lanier LL. Cutting edge: IL-2-induced expression of the amino acid transporters SLC1A5 and CD98 is a prerequisite for NKG2D-mediated activation of human NK cells. J Immunol. 2017;199(6):1967\u201372.","journal-title":"J Immunol"},{"issue":"1","key":"812_CR194","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","volume":"9","author":"RM Loftus","year":"2018","unstructured":"Loftus RM, Assmann N, Kedia-Mehta N, O\u2019Brien KL, Garcia A, Gillespie C, et al. Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice. Nat Commun. 2018;9(1):2341.","journal-title":"Nat Commun"},{"issue":"1","key":"812_CR195","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-024-00481-y","volume":"13","author":"J Shang","year":"2024","unstructured":"Shang J, Hu S, Wang X. Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies. Exp Hematol Oncol. 2024;13(1):21.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"812_CR196","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13045-024-01643-5","volume":"17","author":"H Fang","year":"2024","unstructured":"Fang H, Dai W, Gu R, Zhang Y, Li J, Luo W, et al. myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment. J Hematol Oncol. 2024;17(1):126.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"812_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111516","volume":"41","author":"A Kumar","year":"2022","unstructured":"Kumar A, Yarosz EL, Andren A, Zhang L, Lyssiotis CA, Chang CH. NKT cells adopt a glutamine-addicted phenotype to regulate their homeostasis and function. Cell Rep. 2022;41(4):111516.","journal-title":"Cell Rep"},{"issue":"1","key":"812_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24163","volume":"10","author":"R Yang","year":"2024","unstructured":"Yang R, Cheng S, Xiao J, Pei Y, Zhu Z, Zhang J, et al. GLS and GOT2 as prognostic biomarkers associated with dendritic cell and immunotherapy response in breast cancer. Heliyon. 2024;10(1):e24163.","journal-title":"Heliyon"},{"key":"812_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102575","volume":"59","author":"K Sen","year":"2023","unstructured":"Sen K, Pati R, Jha A, Mishra GP, Prusty S, Chaudhary S, et al. NCoR1 controls immune tolerance in conventional dendritic cells by fine-tuning glycolysis and fatty acid oxidation. Redox Biol. 2023;59:102575.","journal-title":"Redox Biol"},{"issue":"50","key":"812_CR200","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2412157121","volume":"121","author":"GP Lobel","year":"2024","unstructured":"Lobel GP, Han N, Molina Arocho WA, Silber M, Shoush J, Noji MC, et al. Glutamine is critical for the maintenance of type 1 conventional dendritic cells in normal tissue and the tumor microenvironment. Proc Natl Acad Sci USA. 2024;121(50):e2412157121.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"812_CR201","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40164-023-00469-0","volume":"13","author":"M Cao","year":"2024","unstructured":"Cao M, Wang Z, Lan W, Xiang B, Liao W, Zhou J, et al. The roles of tissue resident macrophages in health and cancer. Exp Hematol Oncol. 2024;13(1):3.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"812_CR202","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40164-024-00587-3","volume":"13","author":"K Chen","year":"2024","unstructured":"Chen K, Li Y, Ni J, Yang X, Zhou Y, Pang Y, et al. Identification of a novel subtype of SPP1 + macrophages expressing SIRP\u03b1: implications for tumor immune evasion and treatment response prediction. Exp Hematol Oncol. 2024;13(1):119.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"812_CR203","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41368-021-00128-2","volume":"13","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhang S, Sun J, Wang T, Liu Q, Wu G, et al. Cigarette smoke promotes oral leukoplakia via regulating glutamine metabolism and M2 polarization of macrophage. Int J Oral Sci. 2021;13(1):25.","journal-title":"Int J Oral Sci"},{"issue":"5","key":"812_CR204","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s12276-024-01214-1","volume":"56","author":"DH Kim","year":"2024","unstructured":"Kim DH, Kang YN, Jin J, Park M, Kim D, Yoon G, et al. Glutamine-derived aspartate is required for eIF5A hypusination-mediated translation of HIF-1\u03b1 to induce the polarization of tumor-associated macrophages. Exp Mol Med. 2024;56(5):1123\u201336.","journal-title":"Exp Mol Med"},{"issue":"7","key":"812_CR205","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","volume":"20","author":"EM Palmieri","year":"2017","unstructured":"Palmieri EM, Menga A, Mart\u00edn-P\u00e9rez R, Quinto A, Riera-Domingo C, De Tullio G, et al. Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis. Cell Rep. 2017;20(7):1654\u201366.","journal-title":"Cell Rep"},{"issue":"1","key":"812_CR206","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-024-00550-2","volume":"13","author":"W Chen","year":"2024","unstructured":"Chen W, Chen M, Hong L, Xiahenazi A, Huang M, Tang N, et al. M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis. Exp Hematol Oncol. 2024;13(1):83.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"812_CR207","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"AK Jha","year":"2015","unstructured":"Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42(3):419\u201330.","journal-title":"Immunity"},{"issue":"8","key":"812_CR208","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"A Mantovani","year":"2011","unstructured":"Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11(8):519\u201331.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"812_CR209","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1249\/01.MSS.0000113490.98089.B1","volume":"36","author":"CJ Lagranha","year":"2004","unstructured":"Lagranha CJ, Senna SM, de Lima TM, Silva E, Doi SQ, Curi R, et al. Beneficial effect of glutamine on exercise-induced apoptosis of rat neutrophils. Med Sci Sports Exerc. 2004;36(2):210\u20137.","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"812_CR210","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm.4294","volume":"23","author":"SK Jorch","year":"2017","unstructured":"Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med. 2017;23(3):279\u201387.","journal-title":"Nat Med"},{"issue":"2","key":"812_CR211","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134\u201347.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"812_CR212","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/cs1030403","volume":"103","author":"TC Pithon-Curi","year":"2002","unstructured":"Pithon-Curi TC, Levada AC, Lopes LR, Doi SQ, Curi R. Glutamine plays a role in superoxide production and the expression of p47phox, p22phox and gp91phox in rat neutrophils. Clin Sci (Lond). 2002;103(4):403\u20138.","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"812_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107236","volume":"26","author":"O Kopach","year":"2023","unstructured":"Kopach O, Sylantyev S, Bard L, Michaluk P, Heller JP, Gutierrez Del Arroyo A, et al. Human neutrophils communicate remotely via calcium-dependent glutamate-induced glutamate release. iScience. 2023;26(7):107236.","journal-title":"iScience"},{"issue":"5","key":"812_CR214","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","volume":"54","author":"S Hegde","year":"2021","unstructured":"Hegde S, Leader AM, Merad M. MDSC: markers, development, states, and unaddressed complexity. Immunity. 2021;54(5):875\u201384.","journal-title":"Immunity"},{"issue":"1","key":"812_CR215","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","volume":"21","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yi M, Niu M, Mei Q, Wu K. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. Mol Cancer. 2022;21(1):184.","journal-title":"Mol Cancer"},{"issue":"1","key":"812_CR216","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","volume":"13","author":"J Lu","year":"2024","unstructured":"Lu J, Luo Y, Rao D, Wang T, Lei Z, Chen X, et al. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion. Exp Hematol Oncol. 2024;13(1):39.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"812_CR217","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47096-9","volume":"15","author":"S Daneshmandi","year":"2024","unstructured":"Daneshmandi S, Choi JE, Yan Q, MacDonald CR, Pandey M, Goruganthu M, et al. Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies. Nat Commun. 2024;15(1):2803.","journal-title":"Nat Commun"},{"issue":"41","key":"812_CR218","doi-asserted-by":"publisher","first-page":"15153","DOI":"10.1021\/acs.analchem.2c05734","volume":"95","author":"P Chen","year":"2023","unstructured":"Chen P, Han Y, Wang L, Zheng Y, Zhu Z, Zhao Y, et al. Spatially resolved metabolomics combined with the 3D tumor-immune cell coculture spheroid highlights metabolic alterations during antitumor immune response. Anal Chem. 2023;95(41):15153\u201361.","journal-title":"Anal Chem"},{"issue":"6","key":"812_CR219","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang CH, Qiu J, O\u2019Sullivan D, Buck MD, Noguchi T, Curtis JD, et al. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell. 2015;162(6):1229\u201341.","journal-title":"Cell"},{"issue":"6468","key":"812_CR220","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone RD, Zhao L, Englert JM, Sun IM, Oh MH, Sun IH, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366(6468):1013\u201321.","journal-title":"Science"},{"issue":"12","key":"812_CR221","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70131","volume":"14","author":"C He","year":"2024","unstructured":"He C, Peng M, Zeng X, Dong H, Sun Z, Xu J, et al. Microenvironmental G protein-coupled estrogen receptor-mediated glutamine metabolic coupling between cancer-associated fibroblasts and triple-negative breast cancer cells governs tumour progression. Clin Transl Med. 2024;14(12):e70131.","journal-title":"Clin Transl Med"},{"issue":"1","key":"812_CR222","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C. Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol. 2024;13(1):80.","journal-title":"Exp Hematol Oncol"},{"issue":"6","key":"812_CR223","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s42255-022-00582-0","volume":"4","author":"EJ Kay","year":"2022","unstructured":"Kay EJ, Paterson K, Riera-Domingo C, Sumpton D, D\u00e4britz JHM, Tardito S, et al. Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix. Nat Metab. 2022;4(6):693\u2013710.","journal-title":"Nat Metab"},{"issue":"9","key":"812_CR224","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20241426","volume":"222","author":"X Li","year":"2025","unstructured":"Li X, M\u00f8ller SH, Park J, Chuang YM, Hsueh PC, Chang TH, et al. Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophages. J Exp Med. 2025;222(9):e20241426.","journal-title":"J Exp Med"},{"issue":"2","key":"812_CR225","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1158\/2159-8290.CD-20-0775","volume":"11","author":"R Francescone","year":"2021","unstructured":"Francescone R, Barbosa Vendramini-Costa D, Franco-Barraza J, Wagner J, Muir A, Lau AN, et al. Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast-driven nutritional support and immunosuppression. Cancer Discov. 2021;11(2):446\u201379.","journal-title":"Cancer Discov"},{"issue":"4","key":"812_CR226","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s43018-022-00354-5","volume":"3","author":"J Li","year":"2022","unstructured":"Li J, Ye Y, Liu Z, Zhang G, Dai H, Li J, et al. Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competition. Nat Cancer. 2022;3(4):453\u201370.","journal-title":"Nat Cancer"},{"issue":"7","key":"812_CR227","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1172\/JCI131859","volume":"130","author":"MH Oh","year":"2020","unstructured":"Oh MH, Sun IH, Zhao L, Leone RD, Sun IM, Xu W, et al. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J Clin Invest. 2020;130(7):3865\u201384.","journal-title":"J Clin Invest"},{"issue":"10","key":"812_CR228","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2967\/jnumed.111.101279","volume":"53","author":"K Ploessl","year":"2012","unstructured":"Ploessl K, Wang L, Lieberman BP, Qu W, Kung HF. Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents. J Nucl Med. 2012;53(10):1616\u201324.","journal-title":"J Nucl Med"},{"issue":"274","key":"812_CR229","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa1009","volume":"7","author":"S Venneti","year":"2015","unstructured":"Venneti S, Dunphy MP, Zhang H, Pitter KL, Zanzonico P, Campos C, et al. Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo. Sci Transl Med. 2015;7(274):274ra217.","journal-title":"Sci Transl Med"},{"key":"812_CR230","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12967-015-0581-2","volume":"13","author":"JE Hernandez-Davies","year":"2015","unstructured":"Hernandez-Davies JE, Tran TQ, Reid MA, Rosales KR, Lowman XH, Pan M, et al. Vemurafenib resistance reprograms melanoma cells towards glutamine dependence. J Transl Med. 2015;13:210.","journal-title":"J Transl Med"},{"issue":"1","key":"812_CR231","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s43018-023-00649-1","volume":"5","author":"MV Recouvreux","year":"2024","unstructured":"Recouvreux MV, Grenier SF, Zhang Y, Esparza E, Lambies G, Galapate CM, et al. Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma. Nat Cancer Inst Monogr. 2024;5(1):100\u201313.","journal-title":"Nat Cancer Inst Monogr"},{"issue":"13","key":"812_CR232","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado7808","volume":"10","author":"EB Blatt","year":"2024","unstructured":"Blatt EB, DeBerardinis RJ. Glutamine antagonists may KEAP lung cancer in check. Sci Adv. 2024;10(13):eado7808.","journal-title":"Sci Adv"},{"issue":"13","key":"812_CR233","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adm9859","volume":"10","author":"R Pillai","year":"2024","unstructured":"Pillai R, LeBoeuf SE, Hao Y, New C, Blum JLE, Rashidfarrokhi A, et al. Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer. Sci Adv. 2024;10(13):eadm9859.","journal-title":"Sci Adv"},{"issue":"7","key":"812_CR234","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1158\/2326-6066.CIR-23-1105","volume":"12","author":"M Praharaj","year":"2024","unstructured":"Praharaj M, Shen F, Lee AJ, Zhao L, Nirschl TR, Theodros D, et al. Metabolic reprogramming of tumor-associated macrophages using glutamine antagonist JHU083 drives tumor immunity in myeloid-rich prostate and bladder cancers. Cancer Immunol Res. 2024;12(7):854\u201375.","journal-title":"Cancer Immunol Res"},{"issue":"7","key":"812_CR235","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1038\/oncsis.2017.70","volume":"6","author":"AD Marshall","year":"2017","unstructured":"Marshall AD, van Geldermalsen M, Otte NJ, Lum T, Vellozzi M, Thoeng A, et al. ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma. Oncogenesis. 2017;6(7):e367.","journal-title":"Oncogenesis"},{"issue":"2","key":"812_CR236","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm.4464","volume":"24","author":"ML Schulte","year":"2018","unstructured":"Schulte ML, Fu A, Zhao P, Li J, Geng L, Smith ST, et al. Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med. 2018;24(2):194\u2013202.","journal-title":"Nat Med"},{"issue":"Pt B","key":"812_CR237","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jcis.2022.05.044","volume":"629","author":"Q Jiang","year":"2023","unstructured":"Jiang Q, Lu S, Xu X, Bai C, Yan Q, Fang M, et al. Inhibition of alanine-serine-cysteine transporter 2-mediated auto-enhanced photodynamic cancer therapy of co-nanoassembly between V-9302 and photosensitizer. J Colloid Interface Sci. 2023;629(Pt B):773\u201384.","journal-title":"J Colloid Interface Sci"},{"issue":"1","key":"812_CR238","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37385-x","volume":"9","author":"A Corti","year":"2019","unstructured":"Corti A, Dominici S, Piaggi S, Belcastro E, Chiu M, Taurino G, et al. \u03b3-Glutamyltransferase enzyme activity of cancer cells modulates L-\u03b3-glutamyl-p-nitroanilide (GPNA) cytotoxicity. Sci Rep. 2019;9(1):891.","journal-title":"Sci Rep"},{"issue":"1","key":"812_CR239","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87292-1","volume":"15","author":"LH Alfarsi","year":"2025","unstructured":"Alfarsi LH, Ansari RE, Erkan B, Fakroun A, Craze ML, Aleskandarany MA, et al. SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer. Sci Rep. 2025;15(1):2805.","journal-title":"Sci Rep"},{"issue":"5","key":"812_CR240","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2006203","volume":"16","author":"H Feng","year":"2018","unstructured":"Feng H, Stockwell BR. Unsolved mysteries: How does lipid peroxidation cause ferroptosis? PLoS Biol. 2018;16(5):e2006203.","journal-title":"PLoS Biol"},{"issue":"6486","key":"812_CR241","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020;368(6486):85\u20139.","journal-title":"Science"},{"issue":"7","key":"812_CR242","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41422-022-00642-w","volume":"32","author":"R Yan","year":"2022","unstructured":"Yan R, Xie E, Li Y, Li J, Zhang Y, Chi X, et al. The structure of erastin-bound xCT-4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis. Cell Res. 2022;32(7):687\u201390.","journal-title":"Cell Res"},{"issue":"11","key":"812_CR243","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.ymthe.2020.08.021","volume":"28","author":"J Liu","year":"2020","unstructured":"Liu J, Xia X, Huang P. XCT: a critical molecule that links cancer metabolism to redox signaling. Mol Ther. 2020;28(11):2358\u201366.","journal-title":"Mol Ther"},{"issue":"6","key":"812_CR244","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s10120-017-0720-y","volume":"20","author":"K Shitara","year":"2017","unstructured":"Shitara K, Doi T, Nagano O, Fukutani M, Hasegawa H, Nomura S, et al. Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407). Gastric Cancer. 2017;20(6):1004\u20139.","journal-title":"Gastric Cancer"},{"issue":"9940","key":"812_CR245","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","volume":"384","author":"MS Brose","year":"2014","unstructured":"Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet. 2014;384(9940):319\u201328.","journal-title":"Lancet"},{"issue":"4","key":"812_CR246","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378\u201390.","journal-title":"N Engl J Med"},{"issue":"1","key":"812_CR247","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13046-022-02567-z","volume":"42","author":"Y Li","year":"2023","unstructured":"Li Y, Yang W, Zheng Y, Dai W, Ji J, Wu L, et al. Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis. J Exp Clin Cancer Res. 2023;42(1):6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10064","key":"812_CR248","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","volume":"389","author":"J Bruix","year":"2017","unstructured":"Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;389(10064):56\u201366.","journal-title":"Lancet"},{"issue":"11","key":"812_CR249","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/nm.4407","volume":"23","author":"R Romero","year":"2017","unstructured":"Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nat Med. 2017;23(11):1362\u20138.","journal-title":"Nat Med"},{"issue":"11","key":"812_CR250","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1158\/1535-7163.MCT-21-0071","volume":"20","author":"ME Zavorka Thomas","year":"2021","unstructured":"Zavorka Thomas ME, Lu X, Talebi Z, Jeon JY, Buelow DR, Gibson AA, et al. Gilteritinib inhibits glutamine uptake and utilization in FLT3-ITD-positive AML. Mol Cancer Ther. 2021;20(11):2207\u201317.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"812_CR251","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092151","volume":"14","author":"I B\u00f6hme-Sch\u00e4fer","year":"2022","unstructured":"B\u00f6hme-Sch\u00e4fer I, L\u00f6rentz S, Bosserhoff AK. Role of amino acid transporter SNAT1\/SLC38A1 in human melanoma. Cancers (Basel). 2022;14(9):2151.","journal-title":"Cancers (Basel)"},{"key":"812_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107964","volume":"230","author":"Y Kanai","year":"2022","unstructured":"Kanai Y. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacol Ther. 2022;230:107964.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"812_CR253","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","volume":"13","author":"MI Gross","year":"2014","unstructured":"Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, et al. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther. 2014;13(4):890\u2013901.","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"812_CR254","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1182\/blood-2015-01-621870","volume":"126","author":"N Jacque","year":"2015","unstructured":"Jacque N, Ronchetti AM, Larrue C, Meunier G, Birsen R, Willems L, et al. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood. 2015;126(11):1346\u201356.","journal-title":"Blood"},{"issue":"10","key":"812_CR255","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202305174","volume":"20","author":"Z Li","year":"2024","unstructured":"Li Z, Li X, Lu Y, Zhu X, Zheng W, Chen K, et al. Improved photodynamic therapy based on glutaminase blockage via tumor membrane coated CB-839\/IR-780 nanoparticles. Small. 2024;20(10):e2305174.","journal-title":"Small"},{"issue":"5","key":"812_CR256","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178344","volume":"134","author":"A Mousset","year":"2024","unstructured":"Mousset A, Albrengues J. NETs unleashed: neutrophil extracellular traps boost chemotherapy against colorectal cancer. J Clin Invest. 2024;134(5):e178344.","journal-title":"J Clin Invest"},{"issue":"8","key":"812_CR257","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1158\/1078-0432.CCR-24-3133","volume":"31","author":"KK Ciombor","year":"2025","unstructured":"Ciombor KK, Bae SW, Whisenant JG, Ayers GD, Sheng Q, Peterson TE, et al. Results of the phase I\/II study and preliminary B-cell gene signature of combined inhibition of glutamine metabolism and EGFR in colorectal cancer. Clin Cancer Res. 2025;31(8):1437\u201348.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"812_CR258","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ymthe.2022.12.011","volume":"31","author":"PV Raninga","year":"2023","unstructured":"Raninga PV, He Y, Datta KK, Lu X, Maheshwari UR, Venkat P, et al. Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma. Mol Ther. 2023;31(3):729\u201343.","journal-title":"Mol Ther"},{"issue":"9","key":"812_CR259","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1182\/bloodadvances.2023010950","volume":"8","author":"M Usart","year":"2024","unstructured":"Usart M, Hansen N, Stetka J, Almeida Fonseca T, Guy A, Kimmerlin Q, et al. The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN. Blood Adv. 2024;8(9):2312\u201325.","journal-title":"Blood Adv"},{"issue":"6","key":"812_CR260","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.cmet.2022.04.003","volume":"34","author":"SA Best","year":"2022","unstructured":"Best SA, Gubser PM, Sethumadhavan S, Kersbergen A, Negr\u00f3n Abril YL, Goldford J, et al. Glutaminase inhibition impairs CD8 T cell activation in STK11-\/Lkb1-deficient lung cancer. Cell Metab. 2022;34(6):874-887.e876.","journal-title":"Cell Metab"},{"issue":"6","key":"812_CR261","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1172\/JCI75836","volume":"125","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Stine ZE, Xia J, Lu Y, O\u2019Connor RS, Altman BJ, et al. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J Clin Invest. 2015;125(6):2293\u2013306.","journal-title":"J Clin Invest"},{"issue":"8","key":"812_CR262","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401362","volume":"14","author":"N Zhang","year":"2025","unstructured":"Zhang N, Ping W, Xiang J, Chu S, Li D, Ning S, et al. Biomimetic single-atom nanozyme for dual starvation-enhanced breast cancer immunotherapy. Adv Healthc Mater. 2025;14(8):e2401362.","journal-title":"Adv Healthc Mater"},{"key":"812_CR263","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.actbio.2022.12.052","volume":"158","author":"X Cai","year":"2023","unstructured":"Cai X, Shi S, Chen G, Zhong M, Yang Y, Mai Z, et al. Glutamine metabolism targeting liposomes for synergistic chemosensitization and starvation therapy in ovarian cancer. Acta Biomater. 2023;158:560\u201370.","journal-title":"Acta Biomater"},{"issue":"12","key":"812_CR264","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121749","volume":"11","author":"JJ Wang","year":"2021","unstructured":"Wang JJ, Siu MK, Jiang YX, Leung TH, Chan DW, Wang HG, et al. A combination of glutaminase inhibitor 968 and PD-L1 blockade boosts the immune response against ovarian cancer. Biomolecules. 2021;11(12):1749.","journal-title":"Biomolecules"},{"issue":"1","key":"812_CR265","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41420-021-00590-1","volume":"7","author":"R Yang","year":"2021","unstructured":"Yang R, Guo Z, Zhao Y, Ma L, Li B, Yang C. Compound 968 reverses adriamycin resistance in breast cancer MCF-7(ADR) cells via inhibiting P-glycoprotein function independently of glutaminase. Cell Death Discov. 2021;7(1):204.","journal-title":"Cell Death Discov"},{"key":"812_CR266","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c11037","author":"Z Mai","year":"2023","unstructured":"Mai Z, Zhong J, Zhang J, Chen G, Tang Y, Ma W, et al. Carrier-free immunotherapeutic nano-booster with dual synergistic effects based on glutaminase inhibition combined with photodynamic therapy. ACS Nano. 2023. https:\/\/doi.org\/10.1021\/acsnano.2c11037.","journal-title":"ACS Nano"},{"key":"812_CR267","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106740","volume":"190","author":"Q Wang","year":"2023","unstructured":"Wang Q, Li S, Xu C, Hua A, Wang C, Xiong Y, et al. A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism. Pharmacol Res. 2023;190:106740.","journal-title":"Pharmacol Res"},{"issue":"1","key":"812_CR268","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molcel.2017.11.025","volume":"69","author":"L Jin","year":"2018","unstructured":"Jin L, Chun J, Pan C, Kumar A, Zhang G, Ha Y, et al. The PLAG1-GDH1 axis promotes anoikis resistance and tumor metastasis through CamKK2-AMPK signaling in LKB1-deficient lung cancer. Mol Cell. 2018;69(1):87-99.e87.","journal-title":"Mol Cell"},{"issue":"2","key":"812_CR269","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccell.2014.12.006","volume":"27","author":"L Jin","year":"2015","unstructured":"Jin L, Li D, Alesi GN, Fan J, Kang HB, Lu Z, et al. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell. 2015;27(2):257\u201370.","journal-title":"Cancer Cell"},{"issue":"14","key":"812_CR270","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1158\/1078-0432.CCR-14-1200","volume":"21","author":"P Korangath","year":"2015","unstructured":"Korangath P, Teo WW, Sadik H, Han L, Mori N, Huijts CM, et al. Targeting glutamine metabolism in breast cancer with aminooxyacetate. Clin Cancer Res. 2015;21(14):3263\u201373.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"812_CR271","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41392-022-01266-7","volume":"8","author":"J Jiang","year":"2023","unstructured":"Jiang J, Chen HN, Jin P, Zhou L, Peng L, Huang Z, et al. Targeting PSAT1 to mitigate metastasis in tumors with p53\u201372Pro variant. Signal Transduct Target Ther. 2023;8(1):65.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"812_CR272","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s43018-023-00647-3","volume":"5","author":"J Encarnaci\u00f3n-Rosado","year":"2024","unstructured":"Encarnaci\u00f3n-Rosado J, Sohn ASW, Biancur DE, Lin EY, Osorio-Vasquez V, Rodrick T, et al. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism. Nat Cancer. 2024;5(1):85\u201399.","journal-title":"Nat Cancer"},{"issue":"1","key":"812_CR273","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4599-8","volume":"18","author":"M van Geldermalsen","year":"2018","unstructured":"van Geldermalsen M, Quek LE, Turner N, Freidman N, Pang A, Guan YF, et al. Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways. BMC Cancer. 2018;18(1):689.","journal-title":"BMC Cancer"},{"issue":"3","key":"812_CR274","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369\u201379.","journal-title":"Cell Death Differ"},{"key":"812_CR275","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175913","volume":"955","author":"Q Li","year":"2023","unstructured":"Li Q, Chen K, Zhang T, Jiang D, Chen L, Jiang J, et al. Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy. Eur J Pharmacol. 2023;955:175913.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"812_CR276","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41419-024-06510-2","volume":"15","author":"L Zhu","year":"2024","unstructured":"Zhu L, Hong Y, Zhu Z, Huang J, Wang J, Li G, et al. Fumarate induces LncRNA-MIR4435-2HG to regulate glutamine metabolism remodeling and promote the development of FH-deficient renal cell carcinoma. Cell Death Dis. 2024;15(2):151.","journal-title":"Cell Death Dis"},{"issue":"10","key":"812_CR277","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/s43018-024-00811-3","volume":"5","author":"CD DiNardo","year":"2024","unstructured":"DiNardo CD, Verma D, Baran N, Bhagat TD, Skwarska A, Lodi A, et al. Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b\/2 clinical trial and correlative analyses. Nat Cancer. 2024;5(10):1515\u201333.","journal-title":"Nat Cancer"},{"issue":"36","key":"812_CR278","doi-asserted-by":"publisher","first-page":"E5328","DOI":"10.1073\/pnas.1611406113","volume":"113","author":"A Elgogary","year":"2016","unstructured":"Elgogary A, Xu Q, Poore B, Alt J, Zimmermann SC, Zhao L, et al. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. Proc Natl Acad Sci USA. 2016;113(36):E5328-5336.","journal-title":"Proc Natl Acad Sci USA"},{"key":"812_CR279","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100577","volume":"19","author":"C Yu","year":"2023","unstructured":"Yu C, Wang N, Chen X, Jiang Y, Luan Y, Qin W, et al. A photodynamic-mediated glutamine metabolic intervention nanodrug for triple negative breast cancer therapy. Mater Today Bio. 2023;19:100577.","journal-title":"Mater Today Bio"},{"issue":"12","key":"812_CR280","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.404","volume":"7","author":"JS Lee","year":"2016","unstructured":"Lee JS, Kang JH, Lee SH, Hong D, Son J, Hong KM, et al. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC. Cell Death Dis. 2016;7(12):e2511.","journal-title":"Cell Death Dis"},{"issue":"6","key":"812_CR281","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1039\/D1CB00089F","volume":"2","author":"J Fang","year":"2021","unstructured":"Fang J, Chen Z, Song J, Li J, Han Y, Hou W, et al. Biodegradable self-assembly micelles significantly enhanced the solubility, biological stability and in vivo antitumor efficacy of Hexylselen. RSC Chem Biol. 2021;2(6):1669\u201381.","journal-title":"RSC Chem Biol"},{"issue":"1","key":"812_CR282","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1021\/acsptsci.8b00047","volume":"2","author":"JJ Ruan","year":"2019","unstructured":"Ruan JJ, Yu Y, Hou W, Chen Z, Fang J, Zhang J, et al. Kidney-type glutaminase inhibitor hexylselen selectively kills cancer cells via a three-pronged mechanism. ACS Pharmacol Transl Sci. 2019;2(1):18\u201330.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"14","key":"812_CR283","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202406245","volume":"21","author":"M Zhou","year":"2025","unstructured":"Zhou M, Zhou C, Geng H, Huang Z, Lin Z, Wang Y, et al. EGCG-enabled deep tumor penetration of phosphatase and acidity dual-responsive nanotherapeutics for combinatory therapy of breast cancer. Small. 2025;21(14):e2406245.","journal-title":"Small"},{"key":"812_CR284","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15965","volume":"8","author":"DE Biancur","year":"2017","unstructured":"Biancur DE, Paulo JA, Ma\u0142achowska B, Quiles Del Rey M, Sousa CM, Wang X, et al. Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism. Nat Commun. 2017;8:15965.","journal-title":"Nat Commun"},{"issue":"11","key":"812_CR285","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1016\/j.celrep.2019.02.037","volume":"26","author":"XH Lowman","year":"2019","unstructured":"Lowman XH, Hanse EA, Yang Y, Ishak Gabra MB, Tran TQ, Li H, et al. p53 promotes cancer cell adaptation to glutamine deprivation by upregulating Slc7a3 to increase arginine uptake. Cell Rep. 2019;26(11):3051-3060.e3054.","journal-title":"Cell Rep"},{"issue":"5","key":"812_CR286","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cmet.2018.07.005","volume":"28","author":"M Tajan","year":"2018","unstructured":"Tajan M, Hock AK, Blagih J, Robertson NA, Labuschagne CF, Kruiswijk F, et al. A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3. Cell Metab. 2018;28(5):721-736.e726.","journal-title":"Cell Metab"},{"issue":"7451","key":"812_CR287","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature12138","volume":"497","author":"C Commisso","year":"2013","unstructured":"Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S, et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013;497(7451):633\u20137.","journal-title":"Nature"},{"issue":"3","key":"812_CR288","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.devcel.2019.05.043","volume":"50","author":"SW Lee","year":"2019","unstructured":"Lee SW, Zhang Y, Jung M, Cruz N, Alas B, Commisso C. EGFR-Pak signaling selectively regulates glutamine deprivation-induced macropinocytosis. Dev Cell. 2019;50(3):381-392.e385.","journal-title":"Dev Cell"},{"key":"812_CR289","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2021.09.023","volume":"522","author":"K Hanada","year":"2021","unstructured":"Hanada K, Kawada K, Nishikawa G, Toda K, Maekawa H, Nishikawa Y, et al. Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer. Cancer Lett. 2021;522:129\u201341.","journal-title":"Cancer Lett"},{"issue":"1","key":"812_CR290","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40164-024-00519-1","volume":"13","author":"Z Shi","year":"2024","unstructured":"Shi Z, Hu C, Zheng X, Sun C, Li Q. Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells. Exp Hematol Oncol. 2024;13(1):55.","journal-title":"Exp Hematol Oncol"},{"issue":"10","key":"812_CR291","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.465","volume":"5","author":"CR Rocha","year":"2014","unstructured":"Rocha CR, Garcia CC, Vieira DB, Quinet A, de Andrade-Lima LC, Munford V, et al. Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. Cell Death Dis. 2014;5(10):e1505.","journal-title":"Cell Death Dis"},{"issue":"6","key":"812_CR292","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.gendis.2022.02.009","volume":"9","author":"J Hong","year":"2022","unstructured":"Hong J, Shen YA, Hsu CY, Huang P, Tomaszewski A, Gabrielson E, et al. Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC). Genes Dis. 2022;9(6):1408\u201311.","journal-title":"Genes Dis"},{"key":"812_CR293","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116906","volume":"176","author":"S Guo","year":"2024","unstructured":"Guo S, Wang X, Wang Y, Bai J, Liu Y, Shao Z. The potential therapeutic targets of glutamine metabolism in head and neck squamous cell carcinoma. Biomed Pharmacother. 2024;176:116906.","journal-title":"Biomed Pharmacother"},{"issue":"31","key":"812_CR294","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404375","volume":"11","author":"H Ren","year":"2024","unstructured":"Ren H, Wu Z, Tan J, Tao H, Zou W, Cao Z, et al. Co-delivery nano system of MS-275 and V-9302 induces pyroptosis and enhances anti-tumor immunity against uveal melanoma. Adv Sci (Weinh). 2024;11(31):e2404375.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"812_CR295","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12964-024-02018-6","volume":"23","author":"D Nan","year":"2025","unstructured":"Nan D, Yao W, Huang L, Liu R, Chen X, Xia W, et al. Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets. Cell Commun Signal. 2025;23(1):45.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"812_CR296","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00591-7","volume":"14","author":"H Peng","year":"2025","unstructured":"Peng H, Chao Z, Wang Z, Hao X, Xi Z, Ma S, et al. Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications. Exp Hematol Oncol. 2025;14(1):4.","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"812_CR297","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s43018-020-00160-x","volume":"2","author":"S Wu","year":"2021","unstructured":"Wu S, Fukumoto T, Lin J, Nacarelli T, Wang Y, Ong D, et al. Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. Nat Cancer. 2021;2(2):189\u2013200.","journal-title":"Nat Cancer"},{"issue":"6","key":"812_CR298","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309094","volume":"36","author":"XK Jin","year":"2024","unstructured":"Jin XK, Zhang SM, Liang JL, Zhang SK, Qin YT, Huang QX, et al. A PD-L1-targeting regulator for metabolic reprogramming to enhance glutamine inhibition-mediated synergistic antitumor metabolic and immune therapy. Adv Mater. 2024;36(6):e2309094.","journal-title":"Adv Mater"},{"key":"812_CR299","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jconrel.2023.04.027","volume":"357","author":"L Zhao","year":"2023","unstructured":"Zhao L, Rao X, Zheng R, Huang C, Kong R, Yu X, et al. Targeting glutamine metabolism with photodynamic immunotherapy for metastatic tumor eradication. J Control Release. 2023;357:460\u201371.","journal-title":"J Control Release"},{"issue":"1","key":"812_CR300","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41568-025-00879-8","volume":"26","author":"C Mao","year":"2025","unstructured":"Mao C, Jiang D, Koong AC, Gan B. Exploiting metabolic cell death for cancer therapy. Nat Rev Cancer. 2025;26(1):27\u201345.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"812_CR301","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","volume":"7","author":"WH Yang","year":"2021","unstructured":"Yang WH, Qiu Y, Stamatatos O, Janowitz T, Lukey MJ. Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy. Trends Cancer. 2021;7(8):790\u2013804.","journal-title":"Trends Cancer"},{"issue":"D1","key":"812_CR302","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2024","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2024;53(D1):D1670\u20136.","journal-title":"Nucleic Acids Res"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00812-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00812-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00812-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:03:20Z","timestamp":1787684600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40164-026-00812-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":302,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1186\/s40164-026-00812-1","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"80"}}